Select the Glutathione Drip from our full IV menu or reach out to our team for guidance on the right fit for your goals
For example, in a Phase IIb trial involving 293 adults with obesity and biopsy-confirmed MASH and fibrosis stage F1F3, compared with placebo (14%), once-weekly subcutaneous survodutide at doses of 2.4 mg, 4.8 mg, or 6.0 mg for 24 weeks resulted in significantly greater improvements in MASH with no worsening of fibrosis (47%, 62% and 43%, respectively)
Ongoing follow-up care helps monitor progress, side effects, treatment response, and long-term weight-loss goals
Blood chemistry panels showed no hepatotoxicity (ALT, AST, bilirubin all within normal limits), no nephrotoxicity (creatinine, BUN unchanged), and no hematologic changes
Looking for a targeted approach to weight loss
This vital recycling process is driven by an enzyme called glutathione reductase, which utilizes NADPH (a derivative of vitamin B3) to break the disulfide bond and regenerate two fresh, active GSH molecules